Scoliosis
Pipeline Programs↗
Active Trials↗
Companies Involved↗
Scoliosis is an emerging landscape with 26 programs across 12 companies. The most active players are Vitae Pharmaceuticals Inc., an Allergan affiliate, Revance Therapeutics, Inc., Viatris Specialty LLC. 9 therapies are approved with 6 more in late-stage development.
Intelligence
Pipeline Metrics
Competitive Density
Pipeline Velocity
Mech. Concentration
Completion Rate
Attrition Rate
Competition
Competitive Landscape
Bubble size = clinical trials
Key Players
Top Companies Companies ranked by the number of pipeline programs they run for this disease.
Vitae Pharmaceuticals Inc., an Allergan affiliate
1 program
Revance Therapeutics, Inc.
1 program
Viatris Specialty LLC
1 program
McNeil Consumer & Specialty Pharmaceuticals, a Division of McNeil-PPC, Inc.
1 program
Amring
1 program
Boehringer Ingelheim
1 program
Pipeline
Programs by Phase
Analysis
Trial Status
32
clinical trials
Clinical Trials
Trial Activity
32 trials
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)